Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

242 Press Releases
DateTitleCompany
13 Feb 13 Almac to deliver insight into Supply Chain Management at Clinical Trial Supply Europe Event Almac,
Published by
De Facto Communications
12 Feb 13 Pantarhei Bioscience sells its Estetra shares for the use of Estetrol in oral contraception to Uteron Pharma Pantarhei BioScience,
Published by
De Facto Communications
12 Feb 13 Mallinckrodt Medical BV will promote and distribute Rapiscan® (regadenoson) in France, Italy, Belgium, and Spain Mallinckrodt Medical BV,
Published by
Packer Forbes Communication
12 Feb 13 Recipharm supplies clinical trial material for FDA approved phase IIb study sponsored by PledPharma Recipharm,
Published by
De Facto Communications
07 Feb 13 SMi’s Lyophilisation 2013 – Freeze-Drying for Pharmaceuticals and Biopharmaceuticals SMi Group Ltd
07 Feb 13 Teva Announces First Patient Enrolled in Largest Clinical Study to Date Evaluating AZILECT® for Mild Cognitive Impairment in Parkinson's Disease Teva
07 Feb 13 BioCity Scotland announced as UK hub for major European drug discovery project BioCity Scotland,
Published by
Integra Communications Ltd
06 Feb 13 Almac launches US commercial packaging operations with successful FDA inspection and new client partnership Almac,
Published by
De Facto
05 Feb 13 New Book From RAPS Examines Risk Management for Drugs and Medical Devices Regulatory Affairs Professional Society (RAPS)
05 Feb 13 Further hires including two new senior appointments at the Research Partnership’s new London HQ Research Partnership
05 Feb 13 Senior hires announced at the Access Partnership US and UK Headquarters Access Partnership
05 Feb 13 Recipharm Appoints Prof. Hans Lennernäs to one of its operating Boards Recipharm Pharmaceutical Development AB ,
Published by
De Facto Communications
05 Feb 13 Aesica recruits operations director in formulated products business unit Aesica,
Published by
De Facto Communications
04 Feb 13 eyeforpharma Barcelona 2013 set to top last year’s record numbers eyeforpharma
01 Feb 13 Awards Entries Up Year on Year as Ceremony Synonymous with PM Society Celebrates Creativity in Healthcare Advertising PM Society
01 Feb 13 Clinical Professionals Ranked in Top 2012 Mobile Websites Clinical Professionals,
Published by
Pharmiweb.com
01 Feb 13 Government response to the first ever ‘Youth Select Committee’ The British Youth Council
31 Jan 13 Pharmanet/i3 Renamed Inventiv Health Clinical Pharmanet i3 / Inventiv Health,
Published by
PharmiWeb.com
30 Jan 13 ABPI and PM Society Cement Ties with Joint Working Agreement The PM Society,
Published by
PM Society
30 Jan 13 FDA Advisory Committee Recommends Approval for Boehringer Ingelheim’s Olodaterol* for Maintenance Treatment of COPD Boehringer Ingelheim
29 Jan 13 NEW PRODUCT LAUNCH TARGAXAN® 550 (Rifaximin-alpha 550 mg tablets) launched in the UK Norgine
23 Jan 13 SAFECOM REGULATORY CONFERENCE 2013 - SPEAKERS ANNOUNCED Safeware Quasar Limited,
Published by
JM Marketing
23 Jan 13 Recipharm International Environmental Award 2012 won by Dr. Damia Barcelo Recipharm,
Published by
DeFacto
22 Jan 13 Real world data to prove and improve health outcomes eyeforpharma
22 Jan 13 Domain Therapeutics grants Prexton Therapeutics an exclusive option to license and develop mGluR4 PAMs for Parkinson’s disease Domain Therapeutics S.A. ,
Published by
Andrew Lloyd & Associates
22 Jan 13 Talent Management remains key priority in Life Sciences industry, research finds RSA,
Published by
Say Communications
21 Jan 13 Almac Successfully Completes Knowledge Transfer Partnership with Queens University with Highest Accolade Almac Group,
Published by
De Facto Communications
17 Jan 13 Novartis therapy Exjadeâ„¢, first oral treatment for patients with non-transfusion-dependent thalassaemia now available in the UK Novartis,
Published by
Chandler Chicco Agency
16 Jan 13 CluePoints Launches Powerful & Pragmatic Solution to Risk-Based Monitoring CluePoints
16 Jan 13 Galapagos acquires Cangenix, a structure-based drug discovery company Galapagos NV
Advertising